IRF8 and lung adenocarcinoma: IRF8 promotes MDSC formation in lung adenocarcinoma which lacks experimental verification, especially since IRF8 regulates MDSC differentiation through the IL6-JAK-STAT3 pathway, which only provides us with theoretical insights.